Across TCGA pan-cancer cohorts, ENPP7P13 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of ENPP7P13’s most consistent transcriptional readouts.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where ENPP7P13 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ENPP7P13 is over-expressed in tumor.
LIHC are the cancer types where ENPP7P13 tumor–normal differential expression is most reproducible.